DNA-based vaccine clears nearly half of precancerous cervical lesions in clinical trial

30 septiembre 2015

Using a novel synthetic platform for creating vaccines a team of researchers has successfully eradicated precancerous cervical lesions in nearly half of the women who received an investigational vaccine in a clinical trial.
http://www.sciencedaily.com/releases/2015/09/150930140619.htm

Volver